AMLX · Amylyx Pharmaceuticals, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-10 | Mazzariello Gina |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on April 9, 2026. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.15 to $18.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
15,000 |
| 2026-07-09 | Mazzariello Gina |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on April 9, 2026. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.92 to $18.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
15,000 |
| 2026-06-04 | Quimi Daphne |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |
Stock Option (right to buy)
|
24,372 |
| 2026-06-04 | FONTEYNE PAUL R. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |
Stock Option (right to buy)
|
24,372 |
| 2026-06-04 | Zeiher Bernhardt G |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |
Stock Option (right to buy)
|
24,372 |
| 2026-06-04 | Firestone Karen |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |
Stock Option (right to buy)
|
24,372 |
| 2026-06-04 | MILNE GEORGE M JR |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |
Stock Option (right to buy)
|
24,372 |
| 2026-05-21 | Firestone Karen |
Director |
Buy↑
|
Common Stock
|
3,800 |
| 2026-03-05 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. |
Stock Option (Right to Buy)
|
373,295 |
| 2026-03-05 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. |
Stock Option (Right to Buy)
|
373,295 |
| 2026-03-05 | Mazzariello Gina |
Chief Legal Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. |
Stock Option (Right to Buy)
|
111,990 |
| 2026-03-05 | Bedrosian Camille L |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. |
Stock Option (Right to Buy)
|
143,985 |
| 2026-03-05 | Bedrosian Camille L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. |
Common Stock
|
95,990 |
| 2026-03-05 | FRATES JAMES M |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. |
Stock Option (right to buy)
|
143,985 |
| 2026-03-05 | Mazzariello Gina |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. |
Common Stock
|
74,660 |
| 2026-03-05 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. |
Common Stock
|
248,865 |
| 2026-03-05 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. |
Common Stock
|
248,865 |
| 2026-03-05 | FRATES JAMES M |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. |
Common Stock
|
95,990 |
| 2026-03-02 | Mazzariello Gina |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.400 to $15.070. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
6,844 |
| 2026-03-02 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.450 to $15.160. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
29,282 |
| 2026-03-02 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.450 to $15.360. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
29,282 |
| 2026-03-02 | Bedrosian Camille L |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.440 to $14.945. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
6,461 |
| 2026-03-02 | FRATES JAMES M |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.450 to $15.385. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
7,909 |
| 2026-02-23 | Mazzariello Gina |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.030 to $14.220. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
3,419 |
| 2026-02-02 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.510 to $14.760. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
15,500 |
| 2026-02-02 | FRATES JAMES M |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.460 to $14.790. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
3,557 |
| 2026-02-02 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.510 to $14.760. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
15,500 |
| 2026-02-02 | Mazzariello Gina |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.470 to $14.810. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
3,448 |
| 2026-01-16 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option is fully vested and exercisable. The option is due to expire on February 19, 2026. |
Stock Option (Right to Buy)
|
2,847 |
| 2026-01-16 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option is fully vested and exercisable. The option is due to expire on February 19, 2026. |
Stock Option (Right to Buy)
|
2,818 |
| 2026-01-16 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.82 to $13.835. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
1,974 |
| 2026-01-16 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.83 to $13.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
1,995 |
| 2026-01-16 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Convert↑
|
Common Stock
|
2,818 |
| 2026-01-16 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Convert↑
|
Common Stock
|
2,847 |
| 2026-01-15 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option is fully vested and exercisable. The option is due to expire on February 19, 2026. |
Stock Option (Right to Buy)
|
197,182 |
| 2026-01-15 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Convert↑
|
Common Stock
|
197,153 |
| 2026-01-15 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.26 to $13.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
136,193 |
| 2026-01-15 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.26 to $13.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
136,193 |
| 2026-01-15 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Convert↑
|
Common Stock
|
197,182 |
| 2026-01-15 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option is fully vested and exercisable. The option is due to expire on February 19, 2026. |
Stock Option (Right to Buy)
|
197,153 |
| 2026-01-12 | MILNE GEORGE M JR |
Director |
Gift↓
Filing footnotes — Common Stock (Direct)
Represents a bona fide gift for no consideration. |
Common Stock
|
17,780 |
| 2026-01-06 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.99 to $11.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
7,715 |
| 2026-01-06 | FRATES JAMES M |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.99 to $11.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
3,326 |
| 2026-01-06 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.05 to $11.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
7,715 |
| 2025-12-23 | Firestone Karen |
Director |
Buy↑
|
Common Stock
|
8,100 |
| 2025-12-01 | Bedrosian Camille L |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.30 to $14.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
6,580 |
| 2025-09-30 | Bedrosian Camille L |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.35 to $15.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
12,039 |
| 2025-09-30 | Klee Justin B. |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.99 to $14.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
29,775 |
| 2025-09-30 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.995 to $15.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
200 |
| 2025-09-30 | Cohen Joshua B |
Director, Co-Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.99 to $14.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
Common Stock
|
29,733 |